Hinshaw Recognized as a 2027 “Powerhouse in Litigation” by BTI Consulting
BTI Litigation Outlook 2027 Client Survey
Press Release | 1 min read
Sep 24, 2026
Hinshaw & Culbertson LLP is proud to announce that BTI Consulting has ranked the firm as a “Powerhouse in Litigation”—the highest client satisfaction tier—in its “BTI Litigation Outlook 2027: More Aggressive. More Complexity. Higher Stakes.” client survey.
The survey notes that firms rated as Litigation Powerhouses “are leading the litigation market.” Survey respondents were asked to rate firms based on the following in 10 litigation segments:
-
- Ideas and approaches
-
- Client service
-
- Prior performance
-
- Prowess in dealing with aggressive counsel
About the BTI Litigation Outlook 2027 Survey
The BTI Litigation Outlook 2027 is based on surveys from leading legal decision-makers at organizations with $1 billion or more in revenue across over 15 industries. This detailed analysis takes data from more than 350 interviewees.
According to BTI, the survey targets “the decision-makers in the industries who spend the most on legal affairs as well as thought leaders and innovative corporate counsel.”
The other Litigation Outlook ranking tiers include Leaders, Distinguished, and Standouts.
Related Capabilities
Related Locations
Featured Insights

Webinar
Oct 29, 2026
Carol Rooney Presents on Building a Career in Appellate Practice

In The News
Oct 28, 2026
James Ferrara Comments in The New York Times on Stalled Boca Raton Luxury Condo Project

Insights for Insurers Alert
Oct 28, 2026
Insurance and Reinsurance Commutations, Run-Off, and Loss Portfolio Transfers

Healthcare Alert
Oct 27, 2026
Illinois Medical Aid-in-Dying Law Takes Effect Amid Legal Challenges

In The News
Oct 26, 2026
Scott Seaman Examines the Insurance Coverage Implications of a Recent NFL Concussion Ruling

In The News
Oct 23, 2026
Michael Dowell Discusses Potential Impact of Proposition 44 on California Community Clinics

In The News
Oct 21, 2026
Scott Seaman Says Walmart Ruling is an "Aberration" in the Opioid Insurance Battle





